Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
FDA Confirms CardiAMP HF II May Support Premarket Approval of CardiAMP Cell Therapy for Ischemic HFrEF
-
Abacus Global Management Named to TIME's World's Growth Leaders of 2026
-
Abercrombie & Fitch Expands Retail Presence in SoHo
-
Himalayan Harmony Group Announces 2026 Nepal Online Casino Portfolio With Six Licensed Brands
-
Nano Dimension Issues Letter from Chief Executive Officer, David Stehlin
-
Eos SENOLYTIX Presents Best-in-Class Preclinical Body Composition Data Highlighting Unique Muscle Mass Gains with MitoXcel™ Geropeptide PTC-2105 at the Sachs 2nd Annual Obesity & Cardiometabolic
-
‘Alberta Ag-Plastics. Recycle It!’ Shortlisted for 35th Annual Emerald Awards for Environmental Excellence
-
Hurco Reports Second Quarter Results for Fiscal Year 2026
-
Sinclair Re-Elects Board, Ratifies and Approves Other Proposals
-
Palmetto Publishing Releases Kathleen K. Summers's Gothic Ghost Novel About a Town Erased From Every Map
-
Whoosh Wellness Launches Physician-Guided Telehealth Platform Offering Oral-First Wellness Protocols and Prescribed Microdosing Programs
-
Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease
-
Genius Group Publishes White Paper and Investor Presentation on AI Treasury
-
Village Farms Announces $15 Million Registered Direct Equity Investment from Leading U.S. Institutional Investors
-
Abercrombie & Fitch Expands Retail Presence in SoHo
-
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
MISOORA Unveils Revolutionary K-Beauty Skincare Range Emphasizing Longevity Over Anti-Aging
-
CareCloud Shareholders Overwhelmingly Approve All Proposals, Reaffirming Confidence in Company Leadership and Strategy
-
LGI Homes Celebrates National Homeownership Month
-
Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease
-
Abacus Global Management Named to TIME's World's Growth Leaders of 2026
-
Palmetto Publishing Releases Kathleen K. Summers's Gothic Ghost Novel About a Town Erased From Every Map
-
Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Man Group PLC : Form 8.3 - AMG Critical Materials N.V
-
Man Group PLC : Form 8.3 - Senior plc
-
Man Group PLC : Form 8.3 - Gamma Communications Plc
-
Man Group PLC : Form 8.3 - A consortium comprising LondonMetric Property plc and Schroder Real Estate Investment Trust Limited
-
Sigenergy’s Utility-Scale Energy Storage System Secures Prestigious TÜV SÜD Bankability Report
-
Man Group PLC : Form 8.3 - DCC Plc
-
Correction: UAB “Atsinaujinančios energetikos investicijos” Extended First Tranche Offering Of Notes Under The EUR 25 million Bonds Programme
-
Clearmind Medicine to Feature New Insights from CMND-100 Psychedelic Clinical Trial on “Inside MEAI” Webinar
-
Bombardier's Global 8000, the World’s Fastest Civil Aircraft, Blazes to its First Speed Record Between Montreal, Canada and Nice, France
-
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
FTI Consulting, Inc. Announces $370.0 Million Stock Repurchase Authorization
-
BlockchAIn Announces Pricing of $55 Million Public Offering of Common Stock
-
Bombardier's Global 8000, the World’s Fastest Civil Aircraft, Blazes to its First Speed Record Between Montreal, Canada and Nice, France
-
Form 8.3 - Picton Property Income Limited
-
Result of AGM
-
Auction result of Treasury Bonds - RIKB 38 0215
-
Form 8.3 - LondonMetric Property Plc & Schroder REIT
-
Form 8.3 - Advanced Medical Solutions Group
-
Managers’ Transactions – AS Tallink
-
Seres Therapeutics Announces Two Transactions to Strengthen Balance Sheet, Reduce On-Going Lease Costs and Extend Projected Operating Cash Runway Well Into the First Quarter of 2027
-
McFarlane Lake Announces Closing of $6.75 Million Investment Led by Strategic Investors – Michael Gentile and Pierre Beaudoin
-
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Crypto Projects Shift Toward Real Usage Models as Solana Unchained Pushes Utility-First Design
-
Portillo’s Comes Home to the Heart of Chicago with Plans to Open Landmark Michigan Avenue Restaurant
-
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
G-III Apparel Group, LTD. Reports First Quarter Fiscal 2027 Results and Raises Earnings Guidance
-
Climb Bio Presents CLYM116 Initial Phase 1 Safety Data and Translational Modeling Results at European Renal Association (ERA) Congress 2026 Supporting Continued Development
